American Heart Journal

Papers
(The H4-Index of American Heart Journal is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Information for Readers130
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients112
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER78
In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging75
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial71
Editorial Board70
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function61
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms59
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer51
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study47
Table of Contents45
Table of Contents43
Cardiac auscultation skills among medical trainees40
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig38
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial37
The trial to assess chelation therapy 2 (TACT2): Rationale and design37
Absence of coronary artery disease in patients undergoing coronary imaging and association with amyloidosis: A Danish nationwide study37
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism33
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings32
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study31
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial31
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e31
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study30
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial29
Physician responses to apple watch-detected irregular rhythm alerts28
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China27
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial27
Cardiac rehabilitation availability and characteristics in Latin America and the Caribbean: A Global Comparison27
Ambulatory inotropic therapy: To what end?27
0.15010595321655